Cassiopea S.p.A.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Biotechnology

Other Names/Subsidiaries

  • Cassiopea, Inc.
See more in Biomedtracker

Latest on Cassiopea S.p.A.

Scrip

FDA Import Alert At Sun’s Site: Here’s The Long And Short Of The Impact

 
• By Anju Ghangurde

Sun Pharmaceutical Industries Ltd. ’s Halol facility continues to be stuck in a compliance rut in 2022, after the US Food and Drug Administration (FDA) placed the site under import alert, but analysts

Generics Bulletin

Sun’s Specialty Gambit Paying Off, Tildrakizumab Nears Sales Milestone

 
• By Anju Ghangurde

Sun Pharmaceutical Industries Ltd. 's specialty drugs strategy appears to be paying off with global sales of psoriasis product tildrakizumab (Ilumya/Ilumetri) nearing the half a billion dollar mark an

Scrip

Sun’s Specialty Gambit Paying Off, Tildrakizumab Nears Sales Milestone

 
• By Anju Ghangurde

Sun Pharmaceutical Industries Ltd. 's specialty drugs strategy appears to be paying off with global sales of psoriasis product tildrakizumab (Ilumya/Ilumetri) nearing the half a billion dollar mark an

Scrip

Asia Deal Watch: Huadong Licenses Two Cancer ADCs From Heidelberg Pharma

 
• By Vibha Ravi, Anju Ghangurde, Joseph Haas, and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Huadong Pays $20m Up Front For ADCs Fro